We are live on ! Find out more
COCHW icon

Envoy Medical Warrant
COCHW

39 hedge funds and large institutions have $346K invested in Envoy Medical Warrant in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 5 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

0.74% less ownership

Funds ownership: 34.94% → 34.2% (-0.74%)

5% less funds holding

Funds holding: 41 → 39 (-2)

47% less capital invested

Capital invested by funds: $648K → $346K (-$302K)

60% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 5

67% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 3

Holders
39
Holders Change
-2
Holders Change %
-4.88%
% of All Funds
0.51%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.01%
New
1
Increased
2
Reduced
5
Closed
3
Calls
$10K
Puts
–
Net Calls
+$10K
Net Calls Change
-$54K

Top Buyers

Rank Fund Capital Flow
1
SIM
Sandia Investment Management
Massachusetts
+$36.5K
2
Walleye Trading
Walleye Trading
New York
+$7.56K
3
LSAG
Lake Street Advisors Group
New Hampshire
+$6.18K

Top Sellers

Rank Fund Capital Flow
1
Walleye Capital
Walleye Capital
New York
-$43.2K
2
Man Group
Man Group
United Kingdom
-$10.1K
3
VF
Virtu Financial
New York
-$2K
4
OCAM
Owl Creek Asset Management
New York
-$1.33K
5
WA
Whitebox Advisors
Minnesota
-$618
Name Holding Trade Value Shares
Change 		Change in
Stake
AC
1
Athos Capital
Hong Kong
$45K – – –
AC
2
Aristeia Capital
Connecticut
$41.5K – – –
SIM
3
Sandia Investment Management
Massachusetts
$27.5K +$36.5K +589,886 New
Walleye Trading
4
Walleye Trading
New York
$24.9K +$7.56K +122,304 +30%
EAM
5
Exos Asset Management
New York
$14.5K – – –
CS
6
Clear Street
New York
$14.1K – – –
BNP Paribas Financial Markets
7
BNP Paribas Financial Markets
France
$13.2K – – –
BCL
8
Bracebridge Capital LLC
Massachusetts
$12.2K – – –
DC
9
Diametric Capital
Massachusetts
$12.1K – – –
PAMP
10
Polar Asset Management Partners
Ontario, Canada
$11.9K – – –
AC
11
Antara Capital
New York
$9.74K – – –
Jane Street
12
Jane Street
New York
$9.72K – -4 -0%
Man Group
13
Man Group
United Kingdom
$8.92K -$10.1K -163,008 -47%
WA
14
Whitebox Advisors
Minnesota
$8.13K -$618 -10,000 -5%
MCM
15
Moore Capital Management
New York
$8.12K – – –
VI
16
Vestcor Inc
New Brunswick, Canada
$8K – – –
LSAG
17
Lake Street Advisors Group
New Hampshire
$7.67K +$6.18K +100,000 +100%
SC
18
Sculptor Capital
New York
$6.97K – – –
CSD
19
Clear Street Derivatives
New York
$6.07K – – –
QGA
20
Q Global Advisors
Texas
$6K – – –
Goldman Sachs
21
Goldman Sachs
New York
$5.84K – – –
D.E. Shaw & Co
22
D.E. Shaw & Co
New York
$5.52K – – –
Calamos Advisors
23
Calamos Advisors
Illinois
$4.87K – – –
DCM
24
Dupont Capital Management
Delaware
$4.87K – – –
SRF
25
Silver Rock Financial
California
$3.83K – – –
1
2

COCHW Hedge Fund Activity: Q4 2024 in Review

39 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Envoy Medical Warrant (COCHW) for Q4 2024, worth a combined $346K — down 47% from $648K a quarter earlier.

Sellers outnumbered buyers: 3 funds closed out of COCHW and 1 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 2 added.

The largest buyer was Sandia Investment Management, opening a new position worth an estimated $36.5K. The largest seller was Walleye Capital, cutting an estimated $43.2K.

  • 39 institutional investors held Envoy Medical Warrant (COCHW) as of Q4 2024, down from 41 in Q3 2024.
  • Funds reported $346K of Envoy Medical Warrant stock for Q4 2024, down 47% quarter-over-quarter.
  • 1 fund opened new Envoy Medical Warrant positions in Q4 2024 and 3 closed out, a net change of -2 holders.
  • The largest Envoy Medical Warrant buyer in Q4 2024 was Sandia Investment Management, an estimated $36.5K added.
  • The largest Envoy Medical Warrant seller in Q4 2024 was Walleye Capital, an estimated $43.2K sold.

Based on aggregated 13F filings for Q4 2024.